SLAS2019

Date

Saturday, February 2, 2019 - Wednesday, February 6, 2019

Location

Washington, D.C.
Attendees at SLAS2019

Overview

Charles River is pleased to participate in SLAS2019, the Society for Laboratory Automation and Screening Society's annual flagship International Conference and Exhibition. SLAS2019 will provide a unique combination of education, access to innovative technologies and intelligent peer networking, delivering unmatched value for professionals and students looking to discover the latest life sciences technologies and how they can be applied to drive research objectives.

Schedule a Meeting

For additional information on our conference participation or to schedule a meeting with our attending scientists, please complete the form on the right.

Join us for the following workshops and poster presentations:

 

Presentations

Exhibitor Tutorial: Step-by-Step generation and rapid screening of a 76 billion member therapeutic library against a challenging drug target

Monoclonal antibodies have become one of the most popular pharmaceutical therapeutics. Here we describe the recently Nobel-prize awarded process of generating an antibody library containing billions of unique antibodies, each linked to the unique DNA instructions to make an infinite supply of that drug. We then describe a collection of automation robotics, high-throughput kinetic screening, high-throughput sequencing, immuno-informatics, and high-throughput mammalian expression, that we have connected into a pipeline to enable rapid recovery of high affinity antibodies with rare epitopes against a challenging drug target.

Sarah Ives, PSM, Senior Scientist and Business Development Manager, Distributed Bio
Tuesday, February 5
9:30 – 10:15 a.m.
Room: 143C

 

Workshop

Assay Guidance Workshop for High Throughput Screening and Lead Discovery: System Suitability of In Vitro Screening Assays in Drug Discovery

Viswanath Devanarayan, Global Head of Statistics and Data Sciences, Charles River
Saturday, February 2
8:00 a.m. – 5:00 p.m.
Location TBD

 

Posters

Alzheimer’s disease biomarkers
Viswanath Devanarayan, Global Head of Statistics and Data Sciences, Charles River

Development and validation of ligand-gated ion channel assays using the Qube 384 automated electrophysiology platform
Ian Waddell, Executive Director, Biology, Charles River

Multi-parameter ion channel screening: mechanism-of-action data directly from HTS
David Cronk, Science Director, HTS, Charles River

Robust and scalable generation of stem cell-derived glutamatergic neurons (eNEURON/glut) in support of drug discovery and high throughput screening
Ian Waddell, Executive Director, Biology, Charles River

SuperHuman 2.0: Thousands of hits against any antigen with a computationally optimized repertoire
Sarah Ives, PSM, Senior Scientist and Business Development Manager, Distributed Bio


The Charles River assay development and screening department offers a unique combination of target class and cell biology expertise together with state-of-the-art instrumentation to provide services tailored to your requirements. We provide a collaborative environment and work closely with our teams in medicinal chemistry, ADME, structural biology, and fragment-based drug discovery to deliver within challenging timelines.